COVID-19 & Psychiatry: A Retrospective Chart Review
NCT05244096 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 65000
Last updated 2024-04-05
Summary
A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.
Conditions
Interventions
- OTHER
-
No intervention
Observational study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jeffrey Rado, MD · Northwestern University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-12
- Primary Completion
- 2025-03-30
- Completion
- 2025-03-30
Countries
- United States
Study Locations
More Related Trials
-
Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic
NCT04823988 ·Status: COMPLETED
-
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
NCT05872555 ·Status: ACTIVE_NOT_RECRUITING
-
The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia
NCT01493622 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 ·Status: COMPLETED ·Phase: PHASE3
-
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
NCT02928965 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)
NCT00934466 ·Status: COMPLETED ·Phase: PHASE1
-
Immunity and Infections in the Psychiatric Population
NCT04381845 ·Status: UNKNOWN ·Phase: NA
-
Screening for Childhood-Onset Psychotic Disorders
NCT00049738 ·Status: TERMINATED
-
The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center
NCT05109572 ·Status: COMPLETED
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)
NCT04384419 ·Status: COMPLETED
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Role of Minocycline in First Episode Psychosis
NCT00916461 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Service User and Staff Views on Digital Remote Monitoring for Psychosis
NCT05670197 ·Status: COMPLETED
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
The Covid-19 HEalth caRe wOrkErS (HEROES) Study
NCT04352634 ·Status: UNKNOWN
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia
NCT05839613 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Psychosis-Associated Neuroinflammation in Schizophrenia
NCT02009826 ·Status: COMPLETED
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Cognitive Phenotyping of Severe Psychiatric Disorders (PSYCOG)
NCT05025566 ·Status: NOT_YET_RECRUITING
-
This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.
NCT07184710 ·Status: NOT_YET_RECRUITING